The twisting journey of Pretzel Therapeutics’ top brass appears to have come full circle, with the biotech subsuming the very ...

Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...

It’s been a subdued—albeit sunny—start to healthcare’s biggest conference in San Francisco. | It’s been a subdued—albeit ...

Proceeds to fund clinical development of DIAG723, a first-in-class, disease-modifying therapy designed to correct the root cause of hereditary hemorrhagic telangiectasia and pulmonary arterial ...

Modern medical breakthroughs save lives in ways that feel miraculous, showing how faith and science can work together as ...

Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...

As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.

Long COVID affects an estimated 65 million people worldwide and can damage the brain, heart, blood vessels, and immune system ...

In turn, the company—which is broadly seeking to develop inflammatory drugs targeting the complement system—anticipates ...

A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors ...